Authors
Chutong Lin, Shanwu Ma, Yingze Ning, Huayu He, Jizheng Tang, Liang Jin, Wei He, Zhencheng Xiong, Guangliang Qiang
Published in
IUBMB life. Volume 78. Issue 11.
Abstract
Chemoresistance in non-small cell lung cancer (NSCLC) is frequently accompanied by metabolic reprogramming and immune evasion. ACOT11 (THEM1/STARD14) is an acyl-CoA thioesterase that can tune intracellular free fatty acid (FFA) availability, but the downstream signaling and microenvironmental consequences relevant to resistance remain incompletely defined. ACOT11 expression and prognostic associations were analyzed in TCGA LUAD datasets (DESeq2) and Kaplan-Meier Plotter. ACOT11 levels were validated in paired patient tumor/adjacent tissues (n = 30) by RT-qPCR and immunohistochemistry. Gain- and loss-of-function studies were performed in A549 and NCI-H1975 cells. FFAs were quantified colorimetrically/fluorometrically, while proliferation, clonogenicity, and motility were assessed using CCK-8, colony formation, and Transwell assays. Bioenergetic profiling was performed by Seahorse OCR/ECAR measurements, complemented by ATP and lactate quantification. Neutrophils and CD8+ T cells were isolated from PBMCs for co-culture assays with PD-L1 blockade, and PD-L1 was quantified by flow cytometry and immunoblotting. Tumor growth effects were evaluated in nude mouse xenografts with ACOT11 silencing and neutrophil supplementation. ACOT11 was dysregulated in LUAD and associated with worse survival, and was elevated in clinical tumors at mRNA and protein levels. In NSCLC cells, ACOT11 increased FFA abundance and selectively changes in GPR40 but not GPR120. Exogenous FFA partially rescued the proliferative and migratory defects induced by ACOT11 knockdown, and this rescue was blunted by GPR40 co-silencing. ACOT11 depletion reduced OCR/ECAR, ATP, and lactate output, consistent with impaired energetic capacity, whereas FFA restored these parameters in a GPR40-dependent manner, suggesting that this pathway likely contributes to the observed metabolic effects. ACOT11 aligned with neutrophil-associated inflammatory signatures and increased MPO staining in tumors; ACOT11 loss reduced SPP1/CXCL2 expression, reversible by FFA-GPR40 signaling. Functionally, neutrophils were observed to restore PD-L1 levels and suppress T-cell effector outputs in co-culture settings, and neutrophil supplementation partially rescued xenograft growth; PD-L1 blockade enhanced T-cell cytokine/perforin production and migration. Collectively, these findings support a working model in which ACOT11-associated lipid signaling may contribute to an immunosuppressive milieu involving neutrophils and PD-L1. ACOT11 is associated with increased FFA availability and engagement of a GPR40-linked metabolic program, alongside neutrophil-PD-L1-associated immunosuppression, which may collectively contribute to NSCLC fitness. Targeting components of the ACOT11-FFA-GPR40 pathway, alone or combined with PD-L1 blockade, may represent a mechanistically grounded strategy to weaken tumor bioenergetic reserve and immune escape in NSCLC.
PMID:
43031426
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0